Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
31 EVENTS
1914: Founded as Iwaki Jitaro Shoten (Honsuke-cho 4-chome) as a wholesale drug distributor. Began wholesale to pharmacies, and also started wholesale of pharmaceutical raw materials around this time.
1923: The Great Kanto Earthquake occurred: the store was completely destroyed by the earthquake.
1931: Constructed a new three-story wooden mortar building: established the partnership Iwaki Pharmaceutical Works (later Iwaki Pharmaceutical Co., Ltd.) and began manufacturing pharmaceuticals and pharmaceutical raw materials.
1933: Established the Kanda factory.
1941: World War II began: renamed as Iwaki Shoten Co., Ltd. as a corporate organization.
1945: Tokyo air raids intensified.
1948: Reorganized as Iwaki Pharmaceutical Co., Ltd. Capital 1 million yen. President: Keitaro Iwaki.
1950: Began handling imported pharmaceutical raw materials.
1960: Completion of a five-story building.
1962: Keitaro Iwaki became president.
1963: Renamed to Iwaki Co., Ltd. and listed on the Second Section of the Tokyo Stock Exchange.
1964: Tokyo Olympics held: absorbed Meiji Chemical Industries Co., Ltd., becoming two factories: Kanda and Oji.
1971: Established a Shizuoka factory in Oga-gun, Oita-cho, Shizuoka Prefecture.
1977: Completed wastewater treatment facility at Shizuoka factory (activated sludge).
1981: 50th anniversary of founding.
1983: Closed Oji factory and consolidated into Shizuoka factory.
1987: Completed the K.I. Memorial Hall at Shizuoka factory.
1989: Iwaki Co., Ltd. Headquarters building completed; DMF registration with US FDA; expansion of adjacent land for the second Shizuoka plant: about 60,000 m²; Shizuoka Plant F7 completed.
1990: FDA inspection – compliant.
1994: Ken Taro Iwaki appointed Chairman, Shuu Iwaki appointed President.
1998: GMP-compliant active pharmaceutical ingredient plant (F8) completed at Shizuoka plant.
2005: Listed on Tokyo Stock Exchange First Section; GMP-compliant small-scale production building completed at Shizuoka plant.
2007: Expansion of Shizuoka Plant F8.
2011: Great East Japan Earthquake occurred.
2013: Expansion of manufacturing line F5 at Shizuoka Plant.
2014: 100th anniversary of founding.
2017: Shuu Iwaki appointed Chairman, Keitaro Iwaki appointed President.
2019: North Cube test building for high-activity API completed and commenced operation.
2020: Spel Pharma Inc. joined the group.
Established: July 2020 – founded as a preparatory company, business commenced in June 2021.
2021: Spel Nexus Co., Ltd. – The company name derives from 'Spel' meaning 'hope' and 'Nexus' meaning 'chain, bond'. With the transition to a holding company structure for the group, business was split from the former Iwaki Co., Ltd. and Iwaki Pharmaceutical Co., Ltd., and operations commenced as Spel Nexus Co., Ltd. (registered as a preparatory company in July 2020). Note: The information about Iwaki Co., Ltd. and Iwaki Pharmaceutical Co., Ltd. focuses on the business transferred to Spel Nexus Co., Ltd.
§07
News
4 ARTICLES
Thank You for Visiting CPHI Japan 2026
SpiraneXus Co., Ltd. would like to thank everyone who visited CPHI Japan 2026 held from April 21 to 23, 2026. At our booth, we explained our one-stop pharmaceutical services, high pharmacological activity manufacturing equipment, and contract synthesis services, and we welcome future consultations. We are committed to continuing to provide a wide range of services from early-stage R&D to clinical trial drugs, commercial manufacturing, and raw material procurement.
CPHI Japan 2026 Exhibition Information
Spirax NEXUS Co., Ltd. will exhibit at CPHI Japan 2026, held at Tokyo Big Sight from April 21 to 23, 2026. Our booth is located at 2F-36, and on April 22nd from 15:00 to 15:30, we will introduce our high pharmacological activity raw drug manufacturing equipment and propose contract synthesis services. Prior registration is required to attend.
Speranexus Continues Certification as a Health & Productivity Management Organization in 2026 (Small and Medium-sized Enterprise Sector)
Speranexus Co., Ltd. has been re-certified as a Health & Productivity Management Organization in the small and medium-sized enterprise sector as of March 9, 2026, under the Ministry of Economy, Trade and Industry's system. This is the second consecutive certification since receiving it in 2025. The company plans to continue promoting employee health activities and improving the work environment.
Announcement of EcoVadis Commitment Badge Acquisition
Speranexus Co., Ltd. has obtained the 2025 Commitment Badge in EcoVadis' sustainability assessment. In the evaluation, they scored over 45 points and received high marks in four areas: Environment, Labor and Human Rights, Ethics, and Sustainable Material Procurement. Moving forward, they will continue CSR activities based on 'OUR CREDO' and aim to contribute to the sustainable development of society and the global environment.
§08
Public records
GOV
National Tax Agency basic information8010001211208
Source: National Tax Agency Corporate Number Publication Site, basic three items
Trade name
スペラネクサス株式会社
Trade name (kana)
スペラネクサス
Name in English
Corporation type
301
Address
〒103-0023 東京都中央区日本橋本町4丁目8番2号
Postal code
1030023
Prefecture code
13
City code
102
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2020-07-29
Update date
2020-07-29
Change date
2020-07-29
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
Latest record
1
Excluded from search
0
Processing type
01
Correction type
0
Trade name image ID
Address image ID
Sequence number
2322999
METI gBizINFO8010001211208
Source: gBizINFO (Ministry of Economy, Trade and Industry)